An experimental vaccine at Duke University triggered broadly neutralizing antibodies in a 2019 trial, offering hope for an effective HIV vaccine regimen.
Creating an HIV vaccine has been challenging due to the virus's unique nature; however, this study marks a pivotal advancement in the field.
[
add
]
[
|
|
...
]